Gene · 23607
Papers1,907
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 1,907
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease. | Biochim Biophys Acta Mol Basis Dis | 2019 | 31181293 | PubTator, text mining | PubMed |
| Spatial proteomics reveal that the protein phosphatase PTP1B interacts with and may modify tyrosine phosphorylation of the rhomboid protease RHBDL4. | J Biol Chem | 2019 | 31177093 | PubTator, text mining | PubMed |
| Exosomes as carriers transporting long non‑coding RNAs: Molecular characteristics and their function in cancer (Review). | Mol Med Rep | 2019 | 31173220 | PubTator, text mining | PubMed |
| Endo-lysosomal dysregulations and late-onset Alzheimer's disease: impact of genetic risk factors. | Mol Neurodegener | 2019 | 31159836 | PubTator, text mining | PubMed |
| Transcriptomic analyses reveal the molecular mechanisms of schisandrin B alleviates CCl4-induced liver fibrosis in rats by RNA-sequencing. | Chem Biol Interact | 2019 | 31150632 | PubTator, text mining | PubMed |
| Genotype-phenotype correlation and prognostic impact in Chinese patients with Alport Syndrome. | Mol Genet Genomic Med | 2019 | 31144478 | PubTator, text mining | PubMed |
| CpG-related SNPs in the MS4A region have a dose-dependent effect on risk of late-onset Alzheimer disease. | Aging Cell | 2019 | 31144443 | PubTator, text mining | PubMed |
| The Pro-Oncogenic Adaptor CIN85 Acts as an Inhibitory Binding Partner of Hypoxia-Inducible Factor Prolyl Hydroxylase 2. | Cancer Res | 2019 | 31142511 | PubTator, text mining | PubMed |
| CD2-associated protein (CD2AP) overexpression accelerates amyloid precursor protein (APP) transfer from early endosomes to the lysosomal degradation pathway. | J Biol Chem | 2019 | 31138646 | PubTator, text mining | PubMed |
| Inhibiting Autophagy in Renal Cell Cancer and the Associated Tumor Endothelium. | Cancer J | 2019 | 31135523 | PubTator, text mining | PubMed |
| Excessive apoptosis of podocytes caused by dysregulation of microRNA-182-5p and CD2AP confers to an increased risk of diabetic nephropathy. | J Cell Biochem | 2019 | 31131477 | PubTator, text mining | PubMed |
| Amyloid Beta and MicroRNAs in Alzheimer's Disease. | Front Neurosci | 2019 | 31130840 | PubTator, text mining | PubMed |
| PLEKHA4/kramer Attenuates Dishevelled Ubiquitination to Modulate Wnt and Planar Cell Polarity Signaling. | Cell Rep | 2019 | 31091453 | PubTator, text mining | PubMed |
| Polygenic risk scores for Alzheimer's disease, and academic achievement, cognitive and behavioural measures in children from the general population. | Int J Epidemiol | 2019 | 31056667 | PubTator, text mining | PubMed |
| Plasma Protein and MicroRNA Biomarkers of Insulin Resistance: A Network-Based Integrative -Omics Analysis. | Front Physiol | 2019 | 31024340 | PubTator, text mining | PubMed |
| The Role of p.Ser1105Ser (in NPHS1 Gene) and p.Arg548Leu (in PLCE1 Gene) with Disease Status of Vietnamese Patients with Congenital Nephrotic Syndrome: Benign or Pathogenic? | Medicina (Kaunas) | 2019 | 31013750 | PubTator, text mining | PubMed |
| Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders. | J Neuroimmune Pharmacol | 2019 | 31011884 | PubTator, text mining | PubMed |
| Dominant PAX2 mutations may cause steroid-resistant nephrotic syndrome and FSGS in children. | Pediatr Nephrol | 2019 | 31001663 | PubTator, text mining | PubMed |
| The new genetic landscape of Alzheimer's disease: from amyloid cascade to genetically driven synaptic failure hypothesis? | Acta Neuropathol | 2019 | 30982098 | PubTator, text mining | PubMed |
| Formaldehyde, Epigenetics, and Alzheimer's Disease. | Chem Res Toxicol | 2019 | 30964647 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23607/papers?page=40